Piperazine ferulate–irbesartan combo better than monotherapy in diabetic kidney disease
17 Dec 2020
byJairia Dela Cruz
Piperazine ferulate appears to improve the efficacy of irbesartan in the treatment of diabetic nephropathy, with the combination affording blood glucose control and renal function protection without increasing the incidence of adverse events, according to a study.
